KYOWA KIRIN CO. LTD./ JP3256000005 /
11/13/2024 3:29:02 PM | Chg. -0.3000 | Volume | Bid4:14:04 PM | Ask3:29:03 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
14.7000EUR | -2.00% | 0 Turnover: 0.0000 |
14.7000Bid Size: 341 | 16.6000Ask Size: 302 | 8.42 bill.EUR | - | - |
GlobeNewswire
8/28
Orchard Therapeutics Announces Multiple Presentations from across its Late-stage Neurometabolic Port...
GlobeNewswire
8/8
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
8/1
Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
8/1
BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
GlobeNewswire
8/1
Pharming Group reports second quarter and first half 2024 financial results and provides business up...
GlobeNewswire
7/31
Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Tri...
GlobeNewswire
7/17
Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinical...
GlobeNewswire
6/28
Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Heal...
GlobeNewswire
6/28
Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on Intern...
GlobeNewswire
6/13
Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
GlobeNewswire
5/23
Hornet Therapeutics emerges from stealth with data published in Science demonstrating the first pote...
GlobeNewswire
5/21
Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapano...
GlobeNewswire
5/16
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire
5/8
Pharming Group reports first quarter 2024 financial results and provides business update
GlobeNewswire
5/7
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Ir...